Enfusion Inc (NYSE: ENFN) is 9.07% higher on its value in year-to-date trading and has touched a low of $7.52 and a high of $11.38 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ENFN stock was last observed hovering at around $10.52 in the last trading session, with the day’s gains setting it 0.06%.
Currently trading at $10.58, the stock is 1.71% and 8.53% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing 0.57% at the moment leaves the stock 15.91% off its SMA200. ENFN registered 9.30% gain for a year compared to 6-month gain of 25.95%. The firm has a 50-day simple moving average (SMA 50) of $9.7146 and a 200-day simple moving average (SMA200) of $9.11785.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.12% loss in the last 1 month and extending the period to 3 months gives it a 12.43%, and is -4.08% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.96% over the week and 3.19% over the month.
Enfusion Inc (ENFN) has around 1102 employees, a market worth around $1.37B and $195.16M in sales. Current P/E ratio is 403.82 and Fwd P/E is 36.51. Profit margin for the company is 1.71%. Distance from 52-week low is 40.69% and -6.99% from its 52-week high. The company has generated returns on investments over the last 12 months (3.92%).
with sales reaching $54.66M over the same period.The EPS is expected to grow by 63.13% this year, but quarterly earnings will post 16.56% year-over-year. Quarterly sales are estimated to grow 17.58% in year-over-year returns.
Enfusion Inc (ENFN) Top Institutional Holders
162.0 institutions hold shares in Enfusion Inc (ENFN), with institutional investors hold 102.49% of the company’s shares. The shares outstanding are 93.26M, and float is at 49.54M with Short Float at 1.64%. Institutions hold 96.83% of the Float.
The top institutional shareholder in the company is FTV MANAGEMENT COMPANY, L.P. with over 32.44 million shares valued at $276.39 million. The investor’s holdings represent 36.2427% of the ENFN Shares outstanding. As of 2024-06-30, the second largest holder is ICONIQ CAPITAL, LLC with 14.04 million shares valued at $119.62 million to account for 15.6851 of the shares outstanding. The other top investors are BROWN CAPITAL MANAGEMENT LLC which holds 8.57 million shares representing 9.5795% and valued at over $73.05 million, while HHLR ADVISORS, LTD. holds 5.5583 of the shares totaling 4.98 million with a market value of $42.39 million.
Enfusion Inc (ENFN) Insider Activity
#####
Enfusion Inc disclosed in a document filed with the SEC on Dec 03 ’24 that Pawar Neal (Chief Operating Officer) sold a total of 26,246 shares of the company’s common stock. The trade occurred on Dec 03 ’24 and was made at $10.09 per share for $0.26 million. Following the transaction, the insider now directly holds 1.12 million shares of the ENFN stock.
Still, SEC filings show that on Dec 02 ’24, Pawar Neal (Chief Operating Officer) disposed off 21,801 shares at an average price of $10.03 for $0.22 million. The insider now directly holds 1,143,544 shares of Enfusion Inc (ENFN).
